申请人:Merck Sharp & Dohme Corp.
公开号:US08178546B2
公开(公告)日:2012-05-15
2,5-Diaryl-1,2,4-triazole derivatives of structural formula I are selective inhibitors of the 11β-hydroxysteroid dehydrogenase Type 1 enzyme (11β-HSD-1). The compounds are useful for the treatment of diabetes, hyperglycemia, obesity, insulin resistance, atherosclerosis, dyslipidemia, hyperlipidemia, hypertension, and Metabolic Syndrome. Also disclosed are novel compounds of structural formula II which are inhibitors of 11β-HSD-1.
结构式I中的2,5-二芳基-1,2,4-三唑衍生物是11β-羟基类固醇脱氢酶1型酶(11β-HSD-1)的选择性抑制剂。这些化合物可用于治疗糖尿病、高血糖、肥胖症、胰岛素抵抗、动脉粥样硬化、血脂异常、高脂血症、高血压和代谢综合征。此外,还披露了结构式II的新化合物,它们是11β-HSD-1的抑制剂。